Ajanta Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹1,794 crore and net profit of ₹388 crore for the September 2026 quarter.
Ajanta Pharma (NSE: AJANTPHARM) closed at ₹3,317.70 on 20 Nov 2026, up 32.1% over the past year. Its market capitalisation is ₹41,458 crore and it trades at 32.8 times earnings.
Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.